SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • March 30th, 2015 • CoLucid Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
THIS SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”) is made as of the 12th day of January, 2015, by and among CoLucid Pharmaceuticals, Inc., a Delaware corporation (the “Company”), each of the investors listed on Schedule A hereto (each a “Series A Investor” and collectively, the “Series A Investors”), each of the investors listed on Schedule B hereto (each a “Series B Investor” and collectively, the “Series B Investors”) and each of the investors listed on Schedule C hereto (each a “Series C Investor” and collectively, the “Series C Investors”). The Series A Investors, Series B Investors and Series C Investors are referred to herein individually as an “Investor” and collectively as the “Investors.”
COLUCID PHARMACEUTICALS, INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • March 30th, 2015 • CoLucid Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This Indemnification Agreement (this “Agreement”), dated as of , is entered into by and between CoLucid Pharmaceuticals, Inc., a Delaware corporation (the “Company”) and (“Indemnitee”).
OPTION AGREEMENTOption Agreement • March 30th, 2015 • CoLucid Pharmaceuticals, Inc. • Pharmaceutical preparations
CoLucid Pharmaceuticals, Inc., a Delaware corporation (the “Company”), hereby grants an option to purchase shares of its Common Stock, $0.001 par value per share (“Shares”), pursuant to its 2006 Equity Incentive Plan (the “Plan”), on the terms and conditions stated in the Plan and in this Option Agreement (this “Agreement”), as follows:
CONSULTING AGREEMENTConsulting Agreement • March 30th, 2015 • CoLucid Pharmaceuticals, Inc. • Pharmaceutical preparations • Indiana
This Consulting Agreement (this “Agreement”) is entered into as of September 1, 2008, between CoLucid Pharmaceuticals, Inc., a corporation organized under the laws of Delaware (the “Company”), and LLH Associates, LLC, a limited liability company organized under the laws of New Jersey (the “Consulting Firm”). The Company wishes to retain the Consulting Firm as an independent contractor to perform consulting services for the Company, and the Consulting Firm is willing to perform such services, on the terms set forth herein. The parties hereto have entered into a Confidentiality Agreement, dated as of July 16, 2008 (the “Confidentiality Agreement”), in contemplation of the services referred to herein.
EMPLOYMENT AGREEMENTEmployment Agreement • March 30th, 2015 • CoLucid Pharmaceuticals, Inc. • Pharmaceutical preparations
This Employment Agreement (“Agreement”) is made and entered into effective as of January 13, 2015 (“Effective Date”) by and between CoLucid Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Thomas P. Mathers (“Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • March 30th, 2015 • CoLucid Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (“Agreement”) is made and entered into effective as of February 7, 2015 (“Effective Date”) by and between CoLucid Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Matthew Dallas (“Executive”).
